ZymoGenetics Inc. Newsletter
-
Seattle biotech stalwart ZymoGenetics prepares for year-end closure
01 Nov 2018 17:20 GMT
… .
By
Seattle Times business reporter
ZymoGenetics, the longtime Seattle biotech company … would lease the space, which ZymoGenetics had converted into a biotech … biotech manufacturing plant built by ZymoGenetics in Bothell.
-
Bristol-Myers Squibb plans layoffs of ZymoGenetics' remaining Seattle-area employees
02 Nov 2018 16:01 GMT
-
ZymoGenetics To Cut Workforce By 32%
30 Apr 2009 08:17 GMT
… 2009 (FinancialWire) — ZymoGenetics, Inc. (NASDAQ: ZGEN) said … ;
<p>ZymoGenetics plans to discontinue ongoing … development and commercialization of ZymoGenetics’ product … ;p>Seattle-based ZymoGenetics develops and markets novel …
-
Early exercise disrupts a pro-repair extracellular matrix program during zebrafish fin regeneration
13 Nov 2025 02:06 GMT
… Direct-Zol RNA prep kit (Zymogenetics) and eluted into water. RNA …
-
A life sciences startup will base its headquarters in both Seattle and California. It’s far from the only one
12 Oct 2025 14:24 GMT
… at Seattle-based Immunex and ZymoGenetics.
“I wouldn’t say it …
-
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635
05 Sep 2025 18:00 GMT
… , as VP, Immunology Research at ZymoGenetics, Dr. Gross discovered and developed … of assets, and helped position ZymoGenetics for a successful acquisition by …
-
CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders
10 Sep 2025 11:00 GMT
… his career was CEO of ZymoGenetics (acquired by BMS), and held …
-
eGenesis Appoints Douglas Williams, Ph.D., and Adam Craig, M.D., Ph.D., to its Board of Directors
19 Aug 2025 12:56 GMT
… senior executive roles at Biogen, ZymoGenetics, Amgen, and Seattle Genetics (now …
-
Zillow Group, Inc. Class A (NASDAQ:ZG) Q1 2025 Earnings Call Transcript
08 May 2025 12:46 GMT
… &A Session
Follow Zymogenetics Inc Follow Zymogenetics Inc We may use … may now disconnect.
Follow Zymogenetics Inc Follow Zymogenetics Inc We may use …
-
U.S. Orphan Designated Drugs Market Research Report 2025: $190 Billion Opportunities, Drugs Sales, Price, Dosage & Clinical Trials Insights to 2030 - ResearchAndMarkets.com
19 May 2025 18:48 GMT
…
10.67 XOMA
10.68 ZymoGenetics (BMS)
For more information about …